Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C026486 |
1,2,5,6-dibenzanthracene |
GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
C012277 |
1,2-diamino-4-nitrobenzene |
1,2-diamino-4-nitrobenzene results in increased expression of GSTM1 mRNA | increases expression | 17070881
|
C028328 |
1,2-dichloro-4-nitrobenzene |
GSTM1 protein affects the metabolism of 1,2-dichloro-4-nitrobenzene | affects metabolic processing | 1859377
|
C028328 |
1,2-dichloro-4-nitrobenzene |
GSTM1 protein affects the metabolism of 1,2-dichloro-4-nitrobenzene | affects metabolic processing | 7733673
|
C040756 |
1,2-naphthoquinone |
GSTM1 protein results in decreased susceptibility to 1,2-naphthoquinone | decreases response to substance | 10661898
|
C031763 |
1,3-butadiene |
GSTM1 gene polymorphism promotes the reaction [EPHX1 gene polymorphism results in increased susceptibility to 1,3-butadiene] | increases reaction|increases response to substance | 11238181
|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
GSTM1 protein affects the metabolism of [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 14979731
|
C015262 |
1,6-hexamethylene diisocyanate |
GSTM1 protein polymorphism results in increased susceptibility to 1,6-hexamethylene diisocyanate | increases response to substance | 11927838
|
C042630 |
1-chloro-2,4-dinitrobenzene-glutathione conjugate |
GSTM1 protein affects the metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate | affects metabolic processing | 11684093
|
C035314 |
1-nitropropane |
1-nitropropane results in decreased expression of GSTM1 mRNA | decreases expression | 17070881
|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of GSTM1 mRNA | increases expression | 17070881
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GSTM1 mRNA | affects expression | 21346803
|
C009497 |
2-(4-toluidino)-6-naphthalenesulfonic acid |
2-(4-toluidino)-6-naphthalenesulfonic acid binds to GSTM1 protein | affects binding | 7725348
|
C025235 |
2,6-diaminotoluene |
2,6-diaminotoluene results in decreased expression of GSTM1 mRNA | decreases expression | 17070881
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GSTM1 mRNA | affects expression | 21346803
|
C099328 |
2-allylphenol |
2-allylphenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C099328 |
2-allylphenol |
2-allylphenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C035208 |
2-amino-4,6-dinitrotoluene |
2-amino-4,6-dinitrotoluene affects the expression of GSTM1 mRNA | affects expression | 21346803
|
C014706 |
2-nitro-4-phenylenediamine |
2-nitro-4-phenylenediamine results in increased expression of GSTM1 mRNA | increases expression | 17070881
|
C016617 |
2-nitropropane |
2-nitropropane results in increased expression of GSTM1 mRNA | increases expression | 17070881
|
C082398 |
2-S-glutathionylcaffeic acid |
2-S-glutathionylcaffeic acid results in decreased activity of GSTM1 protein | decreases activity | 8340025
|
C053603 |
3-methylpyridine |
3-methylpyridine results in decreased expression of GSTM1 protein | decreases expression | 7986210
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of GSTM1 mRNA | decreases expression | 18648102
|
C005969 |
4,4'-diphenylmethane diisocyanate |
GSTM1 protein polymorphism results in increased susceptibility to 4,4'-diphenylmethane diisocyanate | increases response to substance | 11927838
|
C028676 |
4-acetylaminofluorene |
4-acetylaminofluorene results in increased expression of GSTM1 mRNA | increases expression | 17070881
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of GSTM1 mRNA | affects expression | 21346803
|
C010407 |
4-chloronitrobenzene |
GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8867999
|
C010407 |
4-chloronitrobenzene |
GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8973562
|
C027576 |
4-hydroxy-2-nonenal |
GSTM1 protein affects the metabolism of 4-hydroxy-2-nonenal analog | affects metabolic processing | 11256969
|
C027576 |
4-hydroxy-2-nonenal |
[GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog | affects binding|affects metabolic processing | 11256969
|
C027576 |
4-hydroxy-2-nonenal |
[GSTM1 protein binds to GSTM3 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog | affects binding|affects metabolic processing | 11256969
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in increased expression of GSTM1 protein | increases expression | 12020353
|
C027576 |
4-hydroxy-2-nonenal |
GSTM1 protein affects the metabolism of 4-hydroxy-2-nonenal analog | affects metabolic processing | 11256969
|
C027576 |
4-hydroxy-2-nonenal |
[GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog | affects binding|affects metabolic processing | 11256969
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of GSTM1 mRNA | decreases expression | 15982314
|
C099327 |
4-propylphenol |
4-propylphenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C099327 |
4-propylphenol |
4-propylphenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C086396 |
5-S-glutathionyl-alpha-methyldopa |
5-S-glutathionyl-alpha-methyldopa results in decreased activity of GSTM1 protein | decreases activity | 8131222
|
C086394 |
5-S-glutathionyldopamine |
5-S-glutathionyldopamine results in decreased activity of GSTM1 protein | decreases activity | 8131222
|
C008450 |
7-methylguanine |
GSTM1 gene polymorphism affects the susceptibility to and affects the metabolism of 7-methylguanine | affects metabolic processing|affects response to substance | 15066569
|
C037112 |
9-deoxy-delta-9-prostaglandin D2 |
GSTM1 protein affects the metabolism of 9-deoxy-delta-9-prostaglandin D2 | affects metabolic processing | 9084911
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of GSTM1 mRNA | decreases expression | 16611625
|
C109238 |
acyline |
acyline results in decreased expression of GSTM1 mRNA | decreases expression | 17510436
|
C006426 |
aflatoxin B1-2,3-oxide |
GSTM1 protein affects the metabolism of and results in decreased activity of aflatoxin B1-2,3-oxide | affects metabolic processing|decreases activity | 1638515
|
D000348 |
Aflatoxins |
GSTM1 gene polymorphism results in increased susceptibility to Aflatoxins | increases response to substance | 15734960
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of GSTM1 mRNA | decreases expression | 15982314
|
C004471 |
allyl isothiocyanate |
GSTM1 protein affects the metabolism of allyl isothiocyanate | affects metabolic processing | 7826396
|
C038491 |
allyl sulfide |
allyl sulfide results in increased expression of GSTM1 mRNA | increases expression | 8627517
|
C038491 |
allyl sulfide |
allyl sulfide results in increased expression of GSTM1 protein | increases expression | 8627517
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GSTM1 mRNA | affects expression | 16483693
|
C019257 |
angelica lactone |
angelica lactone results in increased expression of GSTM1 protein | increases expression | 11309284
|
D001151 |
Arsenic |
GSTM1 gene mutant form results in decreased susceptibility to Arsenic | decreases response to substance | 16353154
|
D001151 |
Arsenic |
GSTM1 gene polymorphism affects the metabolism of and affects the susceptibility to Arsenic | affects metabolic processing|affects response to substance | 17365577
|
D001151 |
Arsenic |
GSTM1 polymorphism affects the metabolism of Arsenic | affects metabolic processing | 17365577
|
D001151 |
Arsenic |
GSTM1 protein affects the susceptibility to Arsenic | affects response to substance | 18053222
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of GSTM1 mRNA | increases expression | 20458559
|
C015001 |
arsenite |
arsenite results in increased expression of GSTM1 mRNA | increases expression | 18929588
|
D001194 |
Asbestos |
GSTM1 gene polymorphism results in increased susceptibility to Asbestos | increases response to substance | 18420450
|
D001205 |
Ascorbic Acid |
GSTM1 gene polymorphism affects the susceptibility to [Ascorbic Acid co-treated with tocotrienol, alpha] | affects cotreatment|affects response to substance | 15668500
|
D001554 |
Benzene |
GSTM1 gene mutant form affects the susceptibility to Benzene | affects response to substance | 14694614
|
D001554 |
Benzene |
GSTM1 gene polymorphism affects the reaction [GSTT1 gene polymorphism affects the reaction [NQO1 gene SNP results in increased susceptibility to Benzene]] | affects reaction|increases response to substance | 17178637
|
D001554 |
Benzene |
GSTM1 gene polymorphism affects the susceptibility to Benzene | affects response to substance | 15226677
|
D001554 |
Benzene |
GSTM1 gene polymorphism results in increased susceptibility to Benzene | increases response to substance | 15226677 15748501
|
D001554 |
Benzene |
GSTM1 protein affects the metabolism of Benzene | affects metabolic processing | 15226677
|
D001554 |
Benzene |
GSTM1 protein results in increased metabolism of Benzene | increases metabolic processing | 17885617
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20045035 18164116
|
D019324 |
beta-Naphthoflavone |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA] | affects cotreatment|decreases reaction|increases expression | 20045035
|
D001564 |
Benzo(a)pyrene |
GSTM1 gene polymorphism affects the susceptibility to Benzo(a)pyrene | affects response to substance | 15471894
|
D001564 |
Benzo(a)pyrene |
GSTM1 gene polymorphism results in increased susceptibility to Benzo(a)pyrene | increases response to substance | 7728947
|
D001564 |
Benzo(a)pyrene |
GSTM1 protein affects the metabolism of [Benzo(a)pyrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
D001564 |
Benzo(a)pyrene |
GSTM1 protein polymorphism affects the metabolism of and affects the activity of Benzo(a)pyrene | affects activity|affects metabolic processing | 15298956
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of GSTM1 mRNA | increases expression | 20127859
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GSTM1 mRNA | increases expression | 19150397
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
GSTM1 protein affects the metabolism of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
GSTM1 protein affects the metabolism of and results in decreased activity of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043
|
C005465 |
benzothiazole |
benzothiazole results in increased expression of GSTM1 mRNA | increases expression | 8951341
|
C012771 |
benzotriazole |
benzotriazole results in increased expression of GSTM1 mRNA | increases expression | 8951341
|
D001583 |
Benzoxazoles |
Benzoxazoles results in increased expression of GSTM1 mRNA | increases expression | 8951341
|
C031403 |
benzyl isothiocyanate |
GSTM1 protein affects the metabolism of benzyl isothiocyanate | affects metabolic processing | 7826396
|
C032036 |
bromobenzene |
bromobenzene metabolite binds to GSTM1 protein | affects binding | 17305373
|
C032036 |
bromobenzene |
bromobenzene results in increased expression of GSTM1 mRNA | increases expression | 12628495
|
C026405 |
bromotriethylstannane |
bromotriethylstannane inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
C026405 |
bromotriethylstannane |
bromotriethylstannane results in decreased activity of GSTM1 protein | decreases activity | 7733673
|
D002066 |
Busulfan |
GSTM1 gene polymorphism affects the susceptibility to Busulfan | affects response to substance | 15142875
|
D002066 |
Busulfan |
GSTM1 protein affects the metabolism of Busulfan | affects metabolic processing | 8886613
|
D002083 |
Butylated Hydroxyanisole |
Butylated Hydroxyanisole results in increased expression of GSTM1 protein | increases expression | 11991805 2597111 11309284
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of GSTM1 mRNA | increases expression | 16436460
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of GSTM1 protein | increases expression | 16436460
|
C053400 |
cafestol |
[cafestol co-treated with kahweol] results in increased expression of GSTM1 protein | affects cotreatment|increases expression | 11346484
|
C053400 |
cafestol |
[cafestol co-treated with kahweol palmitate] results in increased expression of GSTM1 protein | affects cotreatment|increases expression | 11309284
|
C040048 |
caffeic acid |
caffeic acid results in decreased activity of GSTM1 protein | decreases activity | 8340025
|
D002220 |
Carbamazepine |
GSTM1 gene mutant form results in increased susceptibility to Carbamazepine | increases response to substance | 17465707
|
D002246 |
Carbon Disulfide |
GSTM1 gene polymorphism affects the metabolism of Carbon Disulfide | affects metabolic processing | 17333241
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of GSTM1 protein | increases expression | 15650968
|
D002251 |
Carbon Tetrachloride |
[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTM1 protein | affects cotreatment|decreases activity | 12725062
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased activity of GSTM1 protein polymorphism | decreases activity | 12611589
|
D002251 |
Carbon Tetrachloride |
GSTM1 protein polymorphism affects the susceptibility to Carbon Tetrachloride | affects response to substance | 12611589
|
D002251 |
Carbon Tetrachloride |
Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTM1 protein] | affects cotreatment|decreases activity|decreases reaction | 12725062
|
D002509 |
Cephaloridine |
Cephaloridine results in increased expression of GSTM1 mRNA | increases expression | 18172885
|
D002699 |
Chlorambucil |
GSTM1 protein results in decreased susceptibility to Chlorambucil | decreases response to substance | 15044619
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of GSTM1 mRNA | increases expression | 18178546
|
D004390 |
Chlorpyrifos |
Chlorpyrifos affects the expression of GSTM1 mRNA | affects expression | 19440498
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in increased expression of GSTM1 mRNA | increases expression | 17452286
|
C031180 |
chrysene |
GSTM1 protein affects the metabolism of [chrysene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
C012842 |
Cibacron Blue F 3GA |
Cibacron Blue F 3GA inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
C012842 |
Cibacron Blue F 3GA |
Cibacron Blue F 3GA results in decreased activity of GSTM1 protein | decreases activity | 7733673
|
C019304 |
ciprofibrate |
ciprofibrate results in decreased expression of GSTM1 mRNA | decreases expression | 7676460
|
D003024 |
Clozapine |
Clozapine results in increased expression of GSTM1 mRNA | increases expression | 15860345
|
C515714 |
copper (N-2-hydroxyacetophenone)glycinate |
copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTM1 protein | decreases expression | 16289015
|
C515714 |
copper (N-2-hydroxyacetophenone)glycinate |
[copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTM1 protein] which results in increased susceptibility to Doxorubicin | decreases expression|increases response to substance | 16289015
|
C007164 |
cumene hydroperoxide |
GSTM1 protein affects the metabolism of cumene hydroperoxide | affects metabolic processing | 10973735
|
C007164 |
cumene hydroperoxide |
GSTM1 protein affects the metabolism of cumene hydroperoxide | affects metabolic processing | 11684093
|
C057862 |
cyanoginosin LR |
cyanoginosin LR results in decreased expression of GSTM1 mRNA | decreases expression | 17383702
|
C057862 |
cyanoginosin LR |
cyanoginosin LR results in increased expression of GSTM1 mRNA | increases expression | 17654400
|
D003545 |
Cysteine |
Cysteine affects the expression of GSTM1 mRNA | affects expression | 11040448
|
D003561 |
Cytarabine |
GSTM1 gene polymorphism affects the susceptibility to Cytarabine | affects response to substance | 15713801
|
D003630 |
Daunorubicin |
GSTM1 gene polymorphism affects the susceptibility to Daunorubicin | affects response to substance | 15713801
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of GSTM1 mRNA | increases expression | 1394205
|
D003976 |
Diazinon |
Diazinon results in increased expression of GSTM1 mRNA | increases expression | 17452286
|
C041517 |
dibenzo(a,l)pyrene |
GSTM1 protein affects the metabolism of and results in decreased activity of [dibenzo(a,l)pyrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043
|
C061481 |
dibenzoylmethane |
dibenzoylmethane results in increased expression of GSTM1 mRNA | increases expression | 17942926
|
C061481 |
dibenzoylmethane |
[sulforafan co-treated with dibenzoylmethane] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 17942926
|
D002945 |
Cisplatin |
GSTM1 gene polymorphism affects the susceptibility to [Paclitaxel co-treated with Cisplatin] | affects cotreatment|affects response to substance | 12851839
|
D002945 |
Cisplatin |
GSTM1 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
C121718 |
dicyclanil |
dicyclanil results in increased expression of GSTM1 mRNA | increases expression | 15664270
|
D004041 |
Dietary Fats |
[Dietary Fats co-treated with Thioctic Acid] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 18367378
|
D004052 |
Diethylnitrosamine |
[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTM1 protein | affects cotreatment|decreases activity | 12725062
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20045035 18164116
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA | affects cotreatment|decreases expression | 18544905
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 18544905
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
D004052 |
Diethylnitrosamine |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA] | affects cotreatment|decreases reaction|increases expression | 20045035
|
D004052 |
Diethylnitrosamine |
[oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 18754104
|
D004052 |
Diethylnitrosamine |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTM1 protein | affects cotreatment|increases expression | 20935162
|
D004052 |
Diethylnitrosamine |
Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTM1 protein] | affects cotreatment|decreases activity|decreases reaction | 12725062
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in decreased expression of GSTM1 protein] | decreases expression|decreases reaction | 12370186
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 14508638
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 9571047
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 9545290 3570286
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 12069689
|
D004137 |
Dinitrochlorobenzene |
bromotriethylstannane inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
D004137 |
Dinitrochlorobenzene |
Cibacron Blue F 3GA inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
D004137 |
Dinitrochlorobenzene |
Hemin inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
D004137 |
Dinitrochlorobenzene |
Sulfobromophthalein inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
D004137 |
Dinitrochlorobenzene |
triphenyltin chloride inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of Dinitrochlorobenzene | affects metabolic processing | 11368767
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8867999
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 2375757
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione analog] | affects cotreatment|affects metabolic processing | 2375757
|
D004137 |
Dinitrochlorobenzene |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione analog] | affects cotreatment|affects metabolic processing | 2904809
|
D004178 |
Diquat |
Diquat results in decreased expression of GSTM1 mRNA | decreases expression | 7676460
|
D004050 |
Ditiocarb |
Ditiocarb binds to and results in decreased activity of GSTM1 protein | affects binding|decreases activity | 6095330
|
D004298 |
Dopamine |
Dopamine analog results in decreased activity of GSTM1 protein | decreases activity | 8131222
|
D004317 |
Doxorubicin |
[copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTM1 protein] which results in increased susceptibility to Doxorubicin | decreases expression|increases response to substance | 16289015
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of GSTM1 mRNA | increases expression | 16243910
|
D004317 |
Doxorubicin |
GSTM1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 16289015
|
C042986 |
ebselen |
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] | affects binding|decreases activity | 8147899
|
D004811 |
Epichlorohydrin |
GSTM1 gene polymorphism affects the susceptibility to Epichlorohydrin | affects response to substance | 15091291
|
D002393 |
Estrogens, Catechol |
GSTM1 protein affects the metabolism of Estrogens, Catechol metabolite | affects metabolic processing | 15455371
|
D004976 |
Ethacrynic Acid |
GSTM1 protein affects the metabolism of Ethacrynic Acid | affects metabolic processing | 12069689
|
D000431 |
Ethanol |
GSTM1 gene polymorphism affects the susceptibility to Ethanol | affects response to substance | 15932176
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of GSTM1 mRNA | affects expression | 17351261
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of GSTM1 mRNA | decreases expression | 15834898
|
D005015 |
Ethoxyquin |
Ethoxyquin results in increased expression of GSTM1 protein | increases expression | 11309284
|
D005015 |
Ethoxyquin |
Ethoxyquin results in increased expression of GSTM1 protein | increases expression | 8198522
|
D005034 |
Ethylmercuric Chloride |
Ethylmercuric Chloride results in decreased activity of GSTM1 protein | decreases activity | 1793546
|
D005047 |
Etoposide |
GSTM1 gene polymorphism affects the susceptibility to Etoposide | affects response to substance | 15713801
|
D005054 |
Eugenol |
Eugenol analog results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
D005054 |
Eugenol |
Eugenol analog results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
D005227 |
Fatty Acids |
Fatty Acids binds to and results in increased activity of GSTM1 protein | affects binding|increases activity | 2277038
|
D015525 |
Fatty Acids, Omega-3 |
GSTM1 gene polymorphism affects the susceptibility to Fatty Acids, Omega-3 | affects response to substance | 15256483
|
D015725 |
Fluconazole |
Fluconazole results in increased expression of GSTM1 mRNA | increases expression | 16730040
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of GSTM1 mRNA | increases expression | 17070881
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of GSTM1 mRNA | increases expression | 16221962
|
C007835 |
geniposide |
geniposide results in increased expression of GSTM1 mRNA | increases expression | 14646352
|
C007835 |
geniposide |
geniposide results in increased expression of GSTM1 protein | increases expression | 14646352
|
D005961 |
Glucosinolates |
Glucosinolates results in increased expression of GSTM1 protein | increases expression | 15570060
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of Glutathione | affects metabolic processing | 10973735
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 14979731
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of and results in decreased activity of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of and results in decreased activity of [dibenzo(a,l)pyrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing|decreases activity | 11849043
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [Benzo(a)pyrene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [chrysene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 9403173
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of Glutathione | affects metabolic processing | 8886613 9084911 9545290 7826396
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 11368548
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8867999
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8867999
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 2375757
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione analog] | affects cotreatment|affects metabolic processing | 2375757
|
D005978 |
Glutathione |
Glutathione analog binds to and results in decreased activity of GSTM1 protein | affects binding|decreases activity | 1883342
|
D005978 |
Glutathione |
Glutathione deficiency results in increased expression of GSTM1 mRNA | increases expression | 15345336
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 8973562
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione analog] | affects cotreatment|affects metabolic processing | 2904809
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of Glutathione | affects metabolic processing | 6095330
|
D005978 |
Glutathione |
GSTM1 protein affects the metabolism of [styrene oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 2604743
|
D006016 |
Glycolates |
Glycolates analog binds to and results in decreased activity of GSTM1 protein | affects binding|decreases activity | 6686184
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of GSTM1 mRNA | increases expression | 15860345
|
D006427 |
Hemin |
Hemin inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
D006427 |
Hemin |
Hemin results in decreased activity of GSTM1 protein | decreases activity | 7733673
|
D006540 |
Herbicides |
Herbicides binds to and results in decreased activity of GSTM1 protein | affects binding|decreases activity | 6686184
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in decreased expression of GSTM1 mRNA | decreases expression | 15159207
|
C033550 |
hexylglutathione |
hexylglutathione binds to and results in decreased activity of GSTM1 protein | affects binding|decreases activity | 9571047
|
C013026 |
hydratropic aldehyde |
GSTM1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 11368548
|
C013026 |
hydratropic aldehyde |
GSTM1 protein results in decreased activity of hydratropic aldehyde | decreases activity | 11368548
|
C013026 |
hydratropic aldehyde |
hydratropic aldehyde results in decreased activity of GSTM1 protein | decreases activity | 11368548
|
D006861 |
Hydrogen Peroxide |
GSTM1 protein results in decreased susceptibility to Hydrogen Peroxide | decreases response to substance | 10661898
|
C031927 |
hydroquinone |
GSTM1 gene polymorphism affects the susceptibility to hydroquinone | affects response to substance | 15141365
|
C029899 |
imidazole |
imidazole results in increased expression of GSTM1 mRNA | increases expression | 8951341
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in increased expression of GSTM1 protein | increases expression | 11309284
|
D007213 |
Indomethacin |
Indomethacin results in increased expression of GSTM1 mRNA | increases expression | 18299717
|
D007306 |
Insecticides |
GSTM1 gene polymorphism affects the susceptibility to Insecticides | affects response to substance | 12930676
|
D007460 |
Iodoacetamide |
Iodoacetamide results in decreased activity of GSTM1 protein | decreases activity | 1520269
|
D007501 |
Iron |
Iron results in decreased expression of GSTM1 protein | decreases expression | 11755321
|
D007501 |
Iron |
Iron results in increased expression of GSTM1 mRNA | increases expression | 11755321
|
D007501 |
Iron |
Iron results in increased expression of GSTM1 protein | increases expression | 11755321
|
C031050 |
isomethyleugenol |
isomethyleugenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C031050 |
isomethyleugenol |
isomethyleugenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C016527 |
isoquercitrin |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
C016527 |
isoquercitrin |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA] | affects cotreatment|decreases reaction|increases expression | 20045035
|
C053401 |
kahweol |
[cafestol co-treated with kahweol] results in increased expression of GSTM1 protein | affects cotreatment|increases expression | 11346484
|
C033997 |
kahweol palmitate |
[cafestol co-treated with kahweol palmitate] results in increased expression of GSTM1 protein | affects cotreatment|increases expression | 11309284
|
C011890 |
kojic acid |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA | affects cotreatment|decreases expression | 18544905
|
C011890 |
kojic acid |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 18544905
|
C008261 |
lead acetate |
lead acetate affects the localization of GSTM1 protein | affects localization | 9750042
|
C008261 |
lead acetate |
lead acetate results in increased expression of GSTM1 mRNA | increases expression | 9750042
|
C008261 |
lead acetate |
lead acetate results in increased expression of GSTM1 protein | increases expression | 9750042 7878682
|
D008054 |
Lipid Peroxides |
GSTM1 protein affects the metabolism of and results in decreased susceptibility to Lipid Peroxides | affects metabolic processing|decreases response to substance | 9576856
|
D008550 |
Melatonin |
[Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
D015122 |
6-Mercaptopurine |
GSTM1 gene polymorphism affects the susceptibility to 6-Mercaptopurine | affects response to substance | 15713801
|
D008627 |
Mercuric Chloride |
Mercuric Chloride results in increased expression of GSTM1 protein | increases expression | 9434069
|
D008670 |
Metals |
GSTM1 gene polymorphism affects the susceptibility to Metals | affects response to substance | 14504370
|
D008694 |
Methamphetamine |
GSTM1 gene polymorphism affects the susceptibility to Methamphetamine | affects response to substance | 15048646
|
D008727 |
Methotrexate |
GSTM1 gene polymorphism affects the susceptibility to Methotrexate | affects response to substance | 15713801
|
D008750 |
Methyldopa |
Methyldopa analog results in decreased activity of GSTM1 protein | decreases activity | 8131222
|
C005223 |
methyleugenol |
methyleugenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C005223 |
methyleugenol |
methyleugenol results in decreased activity of GSTM1 protein | decreases activity | 8620581
|
C004925 |
methylmercuric chloride |
methylmercuric chloride results in decreased activity of GSTM1 protein | decreases activity | 1793546
|
C020300 |
monomethylarsonic acid |
monomethylarsonic acid results in increased expression of GSTM1 mRNA | increases expression | 16436460
|
C020300 |
monomethylarsonic acid |
monomethylarsonic acid results in increased expression of GSTM1 protein | increases expression | 16436460
|
D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of GSTM1 mRNA | decreases expression | 18955075
|
C031721 |
naphthalene |
naphthalene affects the expression of GSTM1 protein | affects expression | 10959795
|
C014138 |
octachlorostyrene |
octachlorostyrene results in increased expression of GSTM1 mRNA | increases expression | 18036774
|
C026209 |
oltipraz |
oltipraz results in increased expression of GSTM1 mRNA | increases expression | 9203627
|
C011030 |
oxfendazole |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
C011030 |
oxfendazole |
[Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
C011030 |
oxfendazole |
[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 20033131
|
C011030 |
oxfendazole |
[oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 18754104
|
D010126 |
Ozone |
GSTM1 gene polymorphism promotes the reaction [NQO1 gene SNP results in increased susceptibility to Ozone] | increases reaction|increases response to substance | 17652311
|
D010126 |
Ozone |
GSTM1 gene SNP affects the reaction [MS4A2 gene SNP affects the susceptibility to Ozone] | affects reaction|affects response to substance | 18269668
|
D010126 |
Ozone |
GSTM1 gene SNP affects the reaction [TNF gene SNP affects the susceptibility to Ozone] | affects reaction|affects response to substance | 16456144
|
D010126 |
Ozone |
GSTM1 gene SNP results in increased susceptibility to Ozone | increases response to substance | 16870661
|
D010126 |
Ozone |
GSTM1 protein affects the susceptibility to Ozone | affects response to substance | 11371413
|
D010126 |
Ozone |
Ozone results in decreased expression of GSTM1 mRNA | decreases expression | 12763052
|
D017239 |
Paclitaxel |
GSTM1 gene polymorphism affects the susceptibility to [Paclitaxel co-treated with Cisplatin] | affects cotreatment|affects response to substance | 12851839
|
D010269 |
Paraquat |
Paraquat results in increased expression of GSTM1 mRNA | increases expression | 16128001
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid affects the expression of GSTM1 mRNA | affects expression | 18281256
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of GSTM1 mRNA | decreases expression | 18467677
|
C023036 |
perfluorooctanoic acid |
PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of GSTM1 mRNA] | decreases expression|increases reaction | 18467677
|
D010575 |
Pesticides |
GSTM1 gene polymorphism affects the susceptibility to Pesticides | affects response to substance | 15922524 14504370
|
C031181 |
phenanthrene |
GSTM1 gene polymorphism promotes the reaction [CYP1A1 gene polymorphism results in increased metabolism of phenanthrene] | increases metabolic processing|increases reaction | 17035385
|
C058305 |
phenethyl isothiocyanate |
GSTM1 protein affects the metabolism of phenethyl isothiocyanate | affects metabolic processing | 7826396
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of GSTM1 protein | decreases expression | 7986210
|
D010634 |
Phenobarbital |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTM1 protein | affects cotreatment|increases expression | 20935162
|
C509597 |
phenylpropylene oxide |
GSTM1 protein affects the metabolism of phenylpropylene oxide | affects metabolic processing | 17689871
|
D010847 |
Picolines |
Picolines results in decreased expression of GSTM1 protein | decreases expression | 7986210
|
C004479 |
pimagedine |
pimagedine inhibits the reaction [Spermidine results in increased expression of GSTM1 mRNA] | decreases reaction|increases expression | 12763045
|
D010882 |
Piperonyl Butoxide |
Piperonyl Butoxide results in increased expression of GSTM1 mRNA | increases expression | 18544911
|
D010882 |
Piperonyl Butoxide |
Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of GSTM1 mRNA] | increases expression|increases reaction | 18544911
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of GSTM1 mRNA | decreases expression | 18467677
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GSTM1 mRNA] | decreases expression|increases reaction | 18467677
|
D010936 |
Plant Extracts |
Plant Extracts results in increased expression of GSTM1 protein | increases expression | 15570060
|
C095911 |
polycyclic aromatic hydrocarbons-DNA adduct |
GSTM1 protein polymorphism results in increased abundance of polycyclic aromatic hydrocarbons-DNA adduct | increases abundance | 11967624
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
GSTM1 gene polymorphism affects the susceptibility to Polycyclic Hydrocarbons, Aromatic | affects response to substance | 15036119 15466980 15061915
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
GSTM1 protein affects the metabolism of and results in decreased activity of Polycyclic Hydrocarbons, Aromatic | affects metabolic processing|decreases activity | 15122594
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
GSTM1 protein polymorphism results in increased susceptibility to Polycyclic Hydrocarbons, Aromatic | increases response to substance | 11740339
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
GSTM1 protein results in decreased activity of Polycyclic Hydrocarbons, Aromatic | decreases activity | 15122594
|
D011241 |
Prednisone |
GSTM1 gene polymorphism affects the susceptibility to Prednisone | affects response to substance | 15713801
|
C045950 |
propiconazole |
propiconazole affects the expression of GSTM1 mRNA | affects expression | 17383973
|
C100008 |
prostaglandin A2 |
GSTM1 protein affects the metabolism of prostaglandin A2 | affects metabolic processing | 9084911
|
D011719 |
Pyrazines |
Pyrazines results in decreased expression of GSTM1 protein | decreases expression | 7986210
|
C031280 |
pyrazole |
pyrazole results in increased expression of GSTM1 mRNA | increases expression | 17945193
|
C031280 |
pyrazole |
pyrazole results in increased expression of GSTM1 protein | increases expression | 14610226
|
D011802 |
Quinidine |
Quinidine results in decreased activity of GSTM1 protein | decreases activity | 11807801
|
D011803 |
Quinine |
Quinine results in decreased activity of GSTM1 protein | decreases activity | 11807801
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of GSTM1 mRNA | decreases expression | 15982314
|
D012294 |
Rifamycins |
Rifamycins results in decreased expression of GSTM1 protein | decreases expression | 7986210
|
D012982 |
Sodium, Dietary |
GSTM1 gene polymorphism affects the susceptibility to Sodium, Dietary | affects response to substance | 14696128
|
D013095 |
Spermidine |
pimagedine inhibits the reaction [Spermidine results in increased expression of GSTM1 mRNA] | decreases reaction|increases expression | 12763045
|
D013095 |
Spermidine |
Spermidine results in increased expression of GSTM1 mRNA | increases expression | 12763045
|
D020058 |
Styrene |
GSTM1 gene polymorphism affects the susceptibility to Styrene | affects response to substance | 14979085 12717779 14751678
|
D020058 |
Styrene |
GSTM1 gene polymorphism promotes the reaction [GSTT1 gene polymorphism results in increased susceptibility to Styrene] | increases reaction|increases response to substance | 12016165
|
D020058 |
Styrene |
GSTM1 gene polymorphism results in increased susceptibility to Styrene | increases response to substance | 12016165
|
D020058 |
Styrene |
GSTM1 protein affects the reaction [CYP2E1 protein affects the metabolism of Styrene] | affects metabolic processing|affects reaction | 12464798
|
C013690 |
styrene oxide |
GSTM1 protein affects the metabolism of styrene oxide | affects metabolic processing | 11599931 17689871
|
C013690 |
styrene oxide |
GSTM1 protein results in decreased susceptibility to styrene oxide | decreases response to substance | 14698568 11424177
|
C013690 |
styrene oxide |
GSTM1 protein affects the metabolism of styrene oxide | affects metabolic processing | 1638515
|
C013690 |
styrene oxide |
GSTM1 protein affects the metabolism of [styrene oxide co-treated with Glutathione] | affects cotreatment|affects metabolic processing | 2604743
|
D013442 |
Sulfinpyrazone |
Sulfinpyrazone inhibits the reaction [GSTM1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15044619
|
D013448 |
Sulfobromophthalein |
Sulfobromophthalein inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
D013448 |
Sulfobromophthalein |
Sulfobromophthalein results in decreased activity of GSTM1 protein | decreases activity | 7733673
|
C016766 |
sulforafan |
GSTM1 gene polymorphism affects the susceptibility to sulforafan | affects response to substance | 15623468
|
C016766 |
sulforafan |
GSTM1 protein affects the metabolism of sulforafan | affects metabolic processing | 7826396
|
C016766 |
sulforafan |
[sulforafan co-treated with dibenzoylmethane] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 17942926
|
C016766 |
sulforafan |
sulforafan results in increased expression of GSTM1 mRNA | increases expression | 17942926
|
C016766 |
sulforafan |
sulforafan results in increased expression of GSTM1 protein | increases expression | 11309284
|
D013457 |
Sulfur Compounds |
GSTM1 gene polymorphism affects the susceptibility to Sulfur Compounds | affects response to substance | 15033463
|
D013481 |
Superoxides |
GSTM1 protein results in decreased susceptibility to Superoxides | decreases response to substance | 10661898
|
C003377 |
taxifolin |
taxifolin results in increased expression of GSTM1 mRNA | increases expression | 17541156
|
D013662 |
Tea |
Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTM1 protein] | affects cotreatment|decreases activity|decreases reaction | 12725062
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of GSTM1 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | increases expression | 12377990
|
D013749 |
Tetrachlorodibenzodioxin |
NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA] | affects reaction|increases expression | 19474220
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of GSTM1 mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | increases expression | 18172886 18796159 19474220 17949056
|
D013844 |
Thiazoles |
Thiazoles results in increased expression of GSTM1 mRNA | increases expression | 8951341
|
D013844 |
Thiazoles |
Thiazoles results in increased expression of GSTM1 protein | increases expression | 8951341
|
D013853 |
Thioacetamide |
Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in decreased expression of GSTM1 protein] | decreases expression|decreases reaction | 12370186
|
D013853 |
Thioacetamide |
Thioacetamide results in decreased expression of GSTM1 protein | decreases expression | 12370186
|
D013853 |
Thioacetamide |
Thioacetamide results in increased expression of GSTM1 mRNA | increases expression | 15497818
|
D008063 |
Thioctic Acid |
[Dietary Fats co-treated with Thioctic Acid] results in increased expression of GSTM1 mRNA | affects cotreatment|increases expression | 18367378
|
C082032 |
tocotrienol, alpha |
GSTM1 gene polymorphism affects the susceptibility to [Ascorbic Acid co-treated with tocotrienol, alpha] | affects cotreatment|affects response to substance | 15668500
|
D014050 |
Toluene |
GSTM1 gene polymorphism affects the susceptibility to Toluene | affects response to substance | 17292523
|
D014051 |
Toluene 2,4-Diisocyanate |
GSTM1 protein polymorphism results in increased susceptibility to Toluene 2,4-Diisocyanate | increases response to substance | 11927838
|
D014212 |
Tretinoin |
Tretinoin metabolite results in decreased expression of GSTM1 mRNA | decreases expression | 15982314
|
C032910 |
triadimefon |
triadimefon affects the expression of GSTM1 mRNA | affects expression | 17383973
|
D014230 |
Triazoles |
Triazoles results in increased expression of GSTM1 mRNA | increases expression | 8951341
|
C010360 |
triethyllead |
triethyllead results in increased expression of GSTM1 mRNA | increases expression | 9020200
|
C052920 |
trimethylarsine oxide |
trimethylarsine oxide results in increased expression of GSTM1 mRNA | increases expression | 16436460
|
C052920 |
trimethylarsine oxide |
trimethylarsine oxide results in increased expression of GSTM1 protein | increases expression | 16436460
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of GSTM1 mRNA | affects expression | 21346803
|
C012594 |
triphenyltin chloride |
triphenyltin chloride inhibits the reaction [GSTM1 protein affects the metabolism of Dinitrochlorobenzene] | affects metabolic processing|decreases reaction | 7733673
|
C012594 |
triphenyltin chloride |
triphenyltin chloride results in decreased activity of GSTM1 protein | decreases activity | 7733673
|
D014315 |
Triterpenes |
Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of GSTM1 mRNA] | increases expression|increases reaction | 18544911
|
C057693 |
troglitazone |
GSTM1 gene polymorphism affects the susceptibility to troglitazone | affects response to substance | 12732844
|
D014750 |
Vincristine |
GSTM1 gene polymorphism affects the susceptibility to Vincristine | affects response to substance | 15713801
|
D014750 |
Vincristine |
GSTM1 protein results in decreased susceptibility to Vincristine | decreases response to substance | 15044619
|
D014750 |
Vincristine |
Sulfinpyrazone inhibits the reaction [GSTM1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15044619
|
D014752 |
Vinyl Chloride |
GSTM1 gene polymorphism affects the reaction [XRCC1 gene polymorphism affects the reaction [Vinyl Chloride affects the mutagenesis of TP53 gene]] | affects mutagenesis|affects reaction | 16097394
|
D014752 |
Vinyl Chloride |
[GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] results in increased susceptibility to Vinyl Chloride | affects cotreatment|increases response to substance | 16977343
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in increased expression of GSTM1 mRNA | increases expression | 14610226
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-amino-4,6-dinitrotoluene |
34.78 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
34.78 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
34.78 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
34.78 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
34.78 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
34.78 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methylmercuric chloride |
34.78 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
34.78 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
34.78 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
34.78 | 7525203 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
3.86 | 18769834 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
6.47 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
6.47 | 11192467 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
5.04 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
7.92 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
7.92 | 16185265 18769834 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
8.47 | 12690470 15814532 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
Mercuric Chloride |
8.47 | 11274264 |
MESH:D058186 |
Acute Kidney Injury |
|
Superoxides |
8.47 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.00 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
12.47 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.47 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
12.47 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
12.47 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.47 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
12.47 | 16537180 |
MESH:D000230 |
Adenocarcinoma |
|
Vincristine |
12.47 | 19825857 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
18.47 | 10737359 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
18.47 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
18.47 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
18.47 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
18.47 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
18.47 | 11497255 |
MESH:D000236 |
Adenoma |
|
Melatonin |
18.47 | 17195641 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
4.77 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
dicyclanil |
20.09 | 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
20.09 | 19052882 18056438 17620307 17162532 19061943 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
20.09 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
20.09 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
20.09 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
dibenzoylmethane |
7.15 | 17942926 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulforafan |
7.15 | 17942926 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
3.97 | 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
3.86 | 16160616 12649775 14617031 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
10.87 | 11874814 17119214 16611668 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
10.87 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
10.87 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Pesticides |
10.87 | 17119214 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.37 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.08 | 15451039 15451040 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
4,4'-diphenylmethane diisocyanate |
4.81 | 7973495 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
2.58 | 15955085 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
4.43 | 16640825 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.13 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
5.35 | 17627676 15579461 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
5.35 | 16563566 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
5.35 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Plant Extracts |
5.35 | 16962711 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.21 | 10965797 |
MESH:D000740 |
Anemia |
|
4-chloronitrobenzene |
8.89 | 3710033 |
MESH:D000740 |
Anemia |
|
Iron |
8.89 | 16434484 16566752 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.89 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.34 | 11369114 14761424 17661222 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
3.55 | 17147795 17162259 17163184 16569441 17375513 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
7.52 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Superoxides |
7.52 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
2.61 | 10982225 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
3.63 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
2.98 | 11141031 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
3.68 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
7.76 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
7.76 | 10388637 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
6.11 | 16604332 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Quinidine |
6.11 | 18724381 18057881 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.36 | 16835338 12569548 18414634 16251483 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
5.98 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
5.98 | 11256880 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
3.93 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
10.17 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
10.17 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Plant Extracts |
10.17 | 14686799 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
10.17 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
6.30 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
6.30 | 17286800 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
6.30 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
6.30 | 16292516 |
MESH:D001249 |
Asthma |
marker/mechanism |
|
| 16870661 18988661 |
MESH:D001249 |
Asthma |
|
1,6-hexamethylene diisocyanate |
10.94 | 10934080 |
MESH:D001249 |
Asthma |
|
4,4'-diphenylmethane diisocyanate |
10.94 | 11077012 15891530 10934080 6091945 10797510 8156442 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
10.94 | 10378619 |
MESH:D001249 |
Asthma |
|
Ozone |
10.94 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
10.94 | 7684630 6091945 12684321 15855793 170078 12762349 15590890 11077013 3040596 16210060 18394133 10934080 19187332 10797510 15590891 16792590 11467998 20032816 17015710 12585506 11742282 8156442 6091946 |
MESH:D001249 |
Asthma |
|
Tretinoin |
10.94 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
4.23 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
11.41 | 12928151 19371607 |
MESH:D050197 |
Atherosclerosis |
|
Asbestos |
11.41 | 18795166 |
MESH:D050197 |
Atherosclerosis |
|
Carbon Disulfide |
11.41 | 10658303 10367350 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
11.41 | 16640825 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Lipid Peroxides |
11.41 | 16632123 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
6.24 | 18448859 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Pesticides |
6.24 | 20478945 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 16472391 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
4.28 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Cysteine |
4.28 | 19056591 16917939 19267885 |
MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
4.28 | 16920077 |
MESH:D001321 |
Autistic Disorder |
|
Glutathione |
4.28 | 19056591 16917939 19267885 18929414 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
4.28 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
4.28 | 17352947 |
MESH:D001321 |
Autistic Disorder |
|
Melatonin |
4.28 | 16897403 16919138 |
MESH:D001321 |
Autistic Disorder |
|
Pesticides |
4.28 | 17938740 |
MESH:D001327 |
Autoimmune Diseases |
|
sulforafan |
4.39 | 19761891 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
3.98 | 16640825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.23 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
3.79 | 10684365 |
MESH:D001607 |
Berylliosis |
|
Prednisone |
4.51 | 18757698 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
3.78 | 11289319 1440618 |
MESH:D001661 |
Biliary Tract Neoplasms |
|
Vinyl Chloride |
5.62 | 11024202 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
3.35 | 17594078 20046352 |
MESH:D001768 |
Blister |
|
Mustard Gas |
3.94 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
17.13 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
17.13 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.13 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
17.13 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.13 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
1.85 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.00 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
13.31 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
13.31 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
13.31 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
3.43 | 15867366 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
3.79 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
6.53 | 12524144 |
MESH:D002545 |
Brain Ischemia |
|
Plant Extracts |
6.53 | 16041641 |
MESH:D001932 |
Brain Neoplasms |
|
1,3-butadiene |
8.80 | 16860786 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.80 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Vinyl Chloride |
8.80 | 12562636 |
MESH:D001943 |
Breast Neoplasms |
|
1,3-butadiene |
21.13 | 12165863 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
21.13 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
21.13 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
allyl sulfide |
21.13 | 17125941 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
21.13 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
21.13 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
21.13 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
21.13 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
21.13 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
21.13 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
21.13 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
21.13 | 16096432 17426702 18695136 15567936 15939500 15668708 18628466 16935488 16264153 17983394 15136595 11325840 19526202 18234424 16826403 15634643 17369602 15993339 18382427 15692762 15994142 16322301 16115903 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Estrogens, Catechol |
21.13 | 17261777 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
21.13 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Hexachlorobenzene |
21.13 | 12709520 15061365 |
MESH:D001943 |
Breast Neoplasms |
|
indole-3-carbinol |
21.13 | 16082211 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
21.13 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
21.13 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
methyleugenol |
21.13 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
21.13 | 18234424 16244791 18223236 15136595 11325840 16273361 16115903 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Styrene |
21.13 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
21.13 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
21.13 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
21.13 | 16873071 16443354 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
4,4'-diphenylmethane diisocyanate |
8.58 | 8156442 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
8.58 | 18315731 17626835 18417511 19059883 15516495 16777450 14754758 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
8.58 | 15590891 8156442 12507178 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
3.94 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
3.74 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.37 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.18 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
7.43 | 16374292 |
MESH:D002056 |
Burns |
|
Indomethacin |
7.43 | 10459503 |
MESH:D002057 |
Burns, Chemical |
|
Plant Extracts |
4.10 | 9625245 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
8.37 | 15141370 16537180 11239499 15625704 |
MESH:D002100 |
Cachexia |
|
Ozone |
8.37 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
6.52 | 16227642 18705752 15673190 16011737 15721981 3786805 15700767 16050911 10355542 16192424 16097048 16124888 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Melatonin |
6.52 | 15700767 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
3.58 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
1.79 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
2.75 | 17687452 15504454 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
3.92 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
42.30 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
42.30 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
42.30 | 17761372 3581430 6705139 3084413 10737359 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
42.30 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
42.30 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
42.30 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
42.30 | 15073043 16217749 11135700 14691202 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
42.30 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
42.30 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
dicyclanil |
42.30 | 17162532 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
42.30 | 19822196 17138121 20007298 19539802 10737359 17761372 18665156 10672840 16830150 18210153 20935162 3084413 16807293 17978847 19519916 16288022 18494052 19919837 17162532 18506893 18978308 16935385 21159647 20214788 19418558 19171122 18056438 19052882 20512989 20727157 19394651 16569478 20084675 17055752 19335982 19701751 20524982 19208518 16540662 18393292 16698587 17173139 18971187 16328049 18691550 18788625 16681979 20514400 11831363 16502159 20432363 19383236 3581430 19107877 17428255 16878318 20101231 18785209 16779866 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
42.30 | 18059187 17876044 16234567 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
42.30 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethoxyquin |
42.30 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
42.30 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
42.30 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
42.30 | 20935162 20007298 6705139 1701930 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Plant Extracts |
42.30 | 18834353 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
42.30 | 17997003 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
42.30 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vinyl Chloride |
42.30 | 12958735 10699891 12828392 15289165 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
3.52 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.13 | 11352223 14736730 18791128 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.47 | 16685392 12023789 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
3.64 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
9.07 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
9.07 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
9.07 | 17341418 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vincristine |
9.07 | 16201981 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.01 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
18.39 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
18.39 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
18.39 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
18.39 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Glutathione |
18.39 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
18.39 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
18.39 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
18.39 | 16051514 16096774 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Vincristine |
18.39 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
2.99 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.61 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Plant Extracts |
6.61 | 17645561 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.61 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
7.89 | 17007740 17519947 17924179 16109756 15811867 18627295 16278810 15505089 17974986 17131338 16952015 17308081 16242529 16651473 17928571 16364871 16455267 16731534 16612575 15476868 15792986 17329180 16269455 17351982 17382496 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
7.89 | 16640825 |
MESH:D009202 |
Cardiomyopathies |
|
pimagedine |
7.89 | 16612575 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
4.06 | 17334414 16243910 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
4.06 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
4.44 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
4.44 | 16936243 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.23 | 16973168 18022660 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
3.70 | 1977408 15215559 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
13.97 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
13.97 | 10977129 |
MESH:D002386 |
Cataract |
|
pimagedine |
13.97 | 17936468 15003327 |
MESH:D002386 |
Cataract |
|
Tretinoin |
13.97 | 17460283 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
13.97 | 14694615 15817613 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.13 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.13 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.13 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
11.13 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.13 | 2727394 17174075 7505956 21159647 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.06 | 4080065 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
4.63 | 9294310 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.37 | 16129372 |
MESH:D054506 |
Chloracne |
marker/mechanism |
|
| 17101203 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.89 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.89 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
9.89 | 18291259 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
3.93 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.61 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.61 | 11677210 17681005 17110522 16105132 15861022 16919318 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.61 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
3.92 | 16461808 |
MESH:D016770 |
Ciliophora Infections |
|
Quinine |
4.57 | 12113305 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
2.78 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
10.92 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Fluconazole |
10.92 | 16781842 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
10.92 | 15340226 12621046 8697196 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
10.92 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
10.92 | 16781842 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
3.77 | 17123785 |
MESH:D003092 |
Colitis |
|
Tretinoin |
2.54 | 17035595 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
4.49 | 17373747 19159591 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
4.49 | 20423518 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
4.74 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
4.74 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
4.74 | 15936596 15963497 11260862 15786552 15637740 15625704 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
4.74 | 16640825 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.74 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
3.74 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.74 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
3.74 | 12606626 11197048 18059344 17054584 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.74 | 18802399 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
4.24 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
2-amino-4,6-dinitrotoluene |
13.48 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
13.48 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
13.48 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
13.48 | 15095906 |
MESH:D003233 |
Conjunctivitis, Allergic |
|
4,4'-diphenylmethane diisocyanate |
5.20 | 7973495 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.02 | 12609071 |
MESH:D003328 |
Coronary Thrombosis |
|
methyleugenol |
4.60 | 16048847 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
4.48 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
16.55 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
16.55 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
16.55 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
16.55 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
16.55 | 11873399 19302082 10194807 15451039 15451040 15513904 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
16.55 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
16.55 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
16.55 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
16.55 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
16.55 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
16.55 | 9142499 10589399 9664655 17551590 9211117 14991402 9125849 16925845 8800419 9224671 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
16.55 | 16875885 15834900 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.96 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.96 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
11.96 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Glutathione |
5.56 | 19747007 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
5.56 | 19747007 |
MESH:D003643 |
Death |
|
Toluene |
4.43 | 6431079 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
7.12 | 15213294 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
7.12 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
3.47 | 11575062 |
MESH:D003872 |
Dermatitis |
|
Benzene |
3.58 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
1,6-hexamethylene diisocyanate |
12.42 | 18759878 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
12.42 | 14531868 11298694 11906362 8970840 18759878 8156756 2524372 12868966 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diphenylmethane diisocyanate |
12.42 | 18759878 12868966 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
12.42 | 12438553 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
12.42 | 15491423 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
12.42 | 18759878 12956900 15491423 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
1.69 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
5.83 | 3621924 2952479 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
5.83 | 17010967 |
MESH:D009783 |
Dermatitis, Occupational |
|
Vinyl Chloride |
4.50 | 10870345 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
3.95 | 20191521 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
3.39 | 16640825 16604332 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
triphenyltin chloride |
4.45 | 9202216 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
2.82 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
10.24 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
10.24 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
10.24 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
10.24 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
10.24 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
troglitazone |
10.24 | 16023994 |
MESH:D003925 |
Diabetic Angiopathies |
|
troglitazone |
4.45 | 12601628 |
MESH:D003928 |
Diabetic Nephropathies |
|
Plant Extracts |
3.35 | 19706694 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
4.53 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
4.53 | 7907874 7237001 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
4.32 | 15331141 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
4.25 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
marker/mechanism |
|
| 20485159 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
3.52 | 16538176 15057820 20216337 16538175 |
MESH:D056486 |
Drug-Induced Liver Injury |
marker/mechanism |
|
| 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
58.37 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
58.37 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2-amino-4,6-dinitrotoluene |
58.37 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2-nitropropane |
58.37 | 15804453 16445897 20517888 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
58.37 | 16192314 6679447 18289764 11289319 8291058 7440962 9653073 1440618 6482804 18692083 9022650 18648102 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
58.37 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
58.37 | 12392966 12958197 18713872 19739265 15619225 19085960 2444490 15968718 12153990 18071297 10774834 11287661 12594235 19416960 19923254 11834606 14550746 10915739 10663392 16081117 16485898 16227642 19370779 16109766 17562736 17522070 19420014 17906064 19164858 12705907 16393943 14986274 11739529 11421492 11529661 16177239 12540782 11461765 11743745 16781746 14725611 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
allyl sulfide |
58.37 | 15950962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
58.37 | 10092053 12628495 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
58.37 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
58.37 | 17522070 3786805 7440962 15998439 21278145 6623471 16227642 7120509 7179309 10092053 15027814 11566570 10915739 6884620 4309450 15968718 9327722 3732212 2869522 16177239 19085960 19336974 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
58.37 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
cyanoginosin LR |
58.37 | 17654400 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
58.37 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diquat |
58.37 | 18164269 18445702 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
58.37 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
58.37 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
58.37 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
58.37 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tea |
58.37 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
58.37 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
58.37 | 12963478 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
58.37 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
troglitazone |
58.37 | 14986274 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
2.86 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
11.52 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
11.52 | 12231392 12649298 19839026 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
11.52 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
11.52 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
3.93 | 18043480 16133044 18446180 12774134 16326151 17190690 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.00 | 17045617 17202747 17151854 17351913 17329845 10671773 11535926 11991626 11595431 16699067 11595415 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
5.59 | 16402076 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
5.59 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
3.59 | 16487989 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
2.86 | 1851702 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
4.24 | 9068938 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.30 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
16.09 | 19703484 |
MESH:D004487 |
Edema |
|
Indomethacin |
16.09 | 8985016 16100529 10653021 7907874 8273558 7990266 19703484 |
MESH:D004487 |
Edema |
|
Mustard Gas |
16.09 | 11428647 9260866 11402378 11428631 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
16.09 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
16.09 | 12083418 |
MESH:D004487 |
Edema |
|
Plant Extracts |
16.09 | 12787963 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
16.09 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
7.86 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
7.86 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
15-deoxy-delta(12,14)-prostaglandin J2 |
8.99 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
8.99 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.99 | 12538720 |
MESH:D018159 |
Endolymphatic Hydrops |
|
Dimethyl Sulfoxide |
5.32 | 20641076 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.42 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estrogens, Catechol |
7.42 | 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.42 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
5.44 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
5.44 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
9.97 | 18037988 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Plant Extracts |
9.97 | 15268973 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
3.30 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
3.52 | 10567023 16328016 17763956 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
3.79 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
4,4'-diphenylmethane diisocyanate |
11.74 | 8156442 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
11.74 | 11298111 |
MESH:D004802 |
Eosinophilia |
|
Prednisone |
11.74 | 16111148 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
11.74 | 8156442 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
4.09 | 19915237 18855540 16538176 20485159 16415921 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
7.24 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
7.24 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
6.32 | 15008574 16628512 17116037 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
6.32 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
6.55 | 17178248 19439326 18234410 17465707 7988514 821787 20417680 19700373 19620853 9014606 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.55 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Plant Extracts |
6.55 | 19700373 19439326 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.48 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
7.74 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
7.74 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
6.87 | 3659116 15276670 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
6.87 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
3.94 | 9357497 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
4.50 | 19549232 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
3.88 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.43 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.43 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
15.43 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
15.43 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
15.43 | 16785472 15464296 16481741 15173087 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
15.43 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
15.43 | 11005569 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
15.43 | 16481741 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
4.25 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
5.49 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
5.49 | 9664655 16938888 |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
4.53 | 18447907 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
4.48 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
36.62 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
36.62 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
36.62 | 12795759 17595544 12631006 61145 15959796 16045604 16239168 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
36.62 | 18296743 17967931 19551842 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
36.62 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
36.62 | 18620774 19236843 16409862 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
36.62 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
36.62 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
36.62 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Plant Extracts |
36.62 | 15975614 |
MESH:D005234 |
Fatty Liver |
|
Vinyl Chloride |
36.62 | 12197357 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
4.43 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.08 | 16946407 15513904 15451040 10194807 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.27 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
4.22 | 19769572 |
MESH:D005334 |
Fever |
|
4,4'-diphenylmethane diisocyanate |
6.32 | 7973495 |
MESH:D005334 |
Fever |
|
Indomethacin |
6.32 | 17627676 11852909 10431976 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
3.78 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
3.38 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
3.68 | 10962813 |
MESH:D005355 |
Fibrosis |
|
arsenite |
19.50 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
19.50 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
19.50 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
19.50 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.50 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
19.50 | 17994277 |
MESH:D005393 |
Fish Diseases |
|
Quinine |
4.54 | 12113305 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
3.93 | 11298111 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
4.32 | 6392382 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.23 | 16640825 16604332 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.09 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
23.23 | 16983495 |
MESH:D005756 |
Gastritis |
|
Diquat |
23.23 | 15046732 |
MESH:D005756 |
Gastritis |
|
Ethanol |
23.23 | 15046732 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
23.23 | 15046732 |
MESH:D005756 |
Gastritis |
|
Iodoacetamide |
23.23 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.63 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
6.63 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.63 | 17312396 |
MESH:D005910 |
Glioma |
|
1,3-butadiene |
4.59 | 15814359 |
MESH:D005910 |
Glioma |
|
Indomethacin |
4.59 | 16487511 18371953 |
MESH:D005911 |
Gliosis |
|
Paraquat |
3.93 | 11124998 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.24 | 11849393 |
MESH:D006030 |
Glycosuria, Renal |
|
Mercuric Chloride |
4.70 | 2918855 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
2.89 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.35 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.13 | 11248219 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
3.95 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
10.74 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
10.74 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
10.74 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
10.74 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
10.62 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Dimethyl Sulfoxide |
10.62 | 20641076 |
MESH:D034381 |
Hearing Loss |
|
Styrene |
10.62 | 17420221 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
3.92 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.35 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
9.21 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.21 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.21 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.21 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
2.56 | 16244372 12587719 18006777 16707910 17875725 16144979 16330681 17888722 14766674 16244371 16879835 18674790 16495754 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.71 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.71 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Plant Extracts |
6.71 | 18097624 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
9.01 | 6705139 |
MESH:D006390 |
Hemangioendothelioma |
|
Vinyl Chloride |
9.01 | 15380572 |
MESH:D006393 |
Hemangiopericytoma |
|
Vinyl Chloride |
5.62 | 10964802 |
MESH:D006394 |
Hemangiosarcoma |
|
1,3-butadiene |
12.71 | 10930038 2208121 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
12.71 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
12.71 | 15692506 |
MESH:D006394 |
Hemangiosarcoma |
|
Vinyl Chloride |
12.71 | 12958735 12762079 15999577 15989139 11217710 12828392 12211074 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
3.51 | 16183116 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
3.50 | 16604332 16640825 17255318 16574947 17236123 17053826 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.22 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
4-chloronitrobenzene |
8.88 | 3710033 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
8.88 | 16604332 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
7.20 | 15633222 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
7.20 | 18665440 17276928 15929193 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Busulfan |
5.99 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
13.01 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
13.01 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
13.01 | 16487989 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
13.01 | 16456712 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
3.51 | 15135802 |
MESH:D006521 |
Hepatitis, Chronic |
|
Methyldopa |
5.44 | 14986274 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
allyl sulfide |
9.58 | 15950962 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
9.58 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
3.75 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
31.66 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
31.66 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
31.66 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
31.66 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
31.66 | 19176532 16221962 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
propiconazole |
31.66 | 17178688 17178689 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
31.66 | 16120746 15340226 12621046 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
31.66 | 17178688 17178689 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
31.66 | 15817613 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
4.11 | 16490937 16863852 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
4.11 | 7520565 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
6.28 | 10809021 |
MESH:D006561 |
Herpes Simplex |
|
Plant Extracts |
6.28 | 10715843 |
MESH:D015658 |
HIV Infections |
|
Iron |
4.41 | 16597321 |
MESH:D015658 |
HIV Infections |
|
Plant Extracts |
4.41 | 12878215 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
4.51 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
15.05 | 16170182 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
15.05 | 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
15.05 | 15147373 17606976 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
15.05 | 18180244 15147373 16135485 17606976 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Prednisone |
15.05 | 17606976 16135485 16794504 |
MESH:D006689 |
Hodgkin Disease |
|
Vincristine |
15.05 | 15147373 16135485 16794504 17606976 |
MESH:D019584 |
Hot Flashes |
|
Plant Extracts |
3.54 | 14716179 16566672 17454163 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
2.81 | 16354765 15340226 16959395 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
13.70 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
13.70 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
13.70 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
13.70 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
13.70 | 16870215 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
4.48 | 17883296 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.31 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
2.49 | 21332399 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
3.79 | 12524144 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.37 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.10 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
9.61 | 10459572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Plant Extracts |
9.61 | 16484555 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Superoxides |
9.61 | 12615666 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
3.35 | 17050553 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
7.82 | 16046005 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
7.82 | 17658665 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
9.02 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
9.02 | 17546600 |
MESH:D006949 |
Hyperlipidemias |
|
Plant Extracts |
9.02 | 15975614 15268973 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
7.18 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
7.18 | 18773962 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
3.53 | 10880147 11019492 |
MESH:D006973 |
Hypertension |
|
Arsenic |
9.18 | 16076760 9931084 11953799 |
MESH:D006973 |
Hypertension |
|
Benzene |
9.18 | 17940673 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
9.18 | 17042910 |
MESH:D006973 |
Hypertension |
|
Sodium, Dietary |
9.18 | 16870316 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.18 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
2.90 | 15338365 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
4.32 | 16093927 |
MESH:D007006 |
Hypogonadism |
|
Iron |
3.43 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
2.62 | 16569931 16945680 |
MESH:D007022 |
Hypotension |
|
Dopamine |
3.90 | 6740701 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
3.89 | 16640825 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
3.79 | 10574470 18306037 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.13 | 10647630 10651667 16133968 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.13 | 16133044 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.32 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
11.32 | 12948887 16466525 |
MESH:D007248 |
Infertility, Male |
|
Diquat |
11.32 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.32 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
11.32 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
11.32 | 12150543 |
MESH:D007249 |
Inflammation |
|
Benzoxazoles |
25.74 | 2357250 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
25.74 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
25.74 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
25.74 | 18785209 |
MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
25.74 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
25.74 | 12568917 3291741 7812673 |
MESH:D007249 |
Inflammation |
|
Metals |
25.74 | 16786165 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
25.74 | 11428620 11402378 9260866 16001271 17524151 11428647 9357497 11428631 8975870 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
25.74 | 12083418 |
MESH:D007249 |
Inflammation |
|
Plant Extracts |
25.74 | 19332304 12787963 16366677 15997105 |
MESH:D007249 |
Inflammation |
|
Prednisone |
25.74 | 16111148 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
25.74 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
4.18 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
4.18 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
13.93 | 11855677 17329856 18236018 11713966 10210152 15831440 15610444 17994277 11686837 |
MESH:D007410 |
Intestinal Diseases |
|
pimagedine |
13.93 | 11713966 |
MESH:D007410 |
Intestinal Diseases |
|
Superoxides |
13.93 | 10210152 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
13.93 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Plant Extracts |
3.52 | 12351151 12584176 12628509 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.13 | 15241188 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
3.89 | 17163184 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
3.78 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
15.53 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
15.53 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
15.53 | 15992940 17551590 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
15.53 | 15992940 15834900 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
3.79 | 10574470 16133968 18306037 |
MESH:D007642 |
Keratosis |
|
Arsenic |
3.77 | 16930632 12749816 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
4.42 | 16144296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
3.91 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
7.48 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
7.48 | 12649298 15190930 18289764 12231392 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
7.48 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
7.48 | 17190690 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
6.40 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
6.40 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
9.35 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
9.35 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.35 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Vinyl Chloride |
9.35 | 12562636 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
3.57 | 11231351 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
3.95 | 9562676 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.05 | 15451040 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
2.88 | 12228301 10320625 11703811 |
MESH:D007938 |
Leukemia |
marker/mechanism |
|
| 14694614 18505952 |
MESH:D007938 |
Leukemia |
|
1,3-butadiene |
8.50 | 16155477 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
8.50 | 15070760 |
MESH:D007938 |
Leukemia |
|
Benzene |
8.50 | 14694614 18335105 15935818 17119257 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
8.50 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
10.14 | 16085563 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
troglitazone |
10.14 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
2.68 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.10 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
8.61 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Busulfan |
8.61 | 10373061 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
8.61 | 10785260 15631656 16572323 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.59 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
9.59 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.59 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.16 | 16467208 19850784 16968895 17050201 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
5.16 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
5.16 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.16 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.38 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.38 | 15213294 16330433 17217047 16966277 19642359 19225113 19075265 12018890 9834237 16331271 17107899 15336539 17649720 15622746 11468182 15748426 19035177 12679006 12712474 11161223 16823087 17869043 17712046 16112521 16891316 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.38 | 17506722 16788101 19225113 19075265 19029980 16823087 17301526 17294898 16140955 16766008 17217047 16891316 17368321 15748426 16935935 17339181 12679006 17107899 9834237 16331271 19642359 17649720 17712046 19035177 17361223 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.18 | 16882451 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.13 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
4.48 | 17980183 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.23 | 16563566 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.01 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
5.06 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
5.06 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.01 | 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
3.67 | 17353645 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
4.48 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
29.53 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
29.53 | 16221502 16943688 17334410 11408273 17157831 17174718 11903743 21278145 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
29.53 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
29.53 | 18665156 19638242 20032147 18407596 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
29.53 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
29.53 | 16640825 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
29.53 | 14986274 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
29.53 | 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
Plant Extracts |
29.53 | 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Vinyl Chloride |
29.53 | 12958735 15354062 11679801 15289165 12499459 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
3.88 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.29 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
marker/mechanism |
|
| 15650968 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
18.41 | 13678700 12666154 12546737 17823541 18395914 18376398 12898905 14512876 17557913 15370692 15818738 15730626 18412020 16015684 16116963 17714472 18420326 18472332 15057751 12445418 17631135 16136751 16192424 15673190 18705752 16638106 12667390 16248980 14716833 18054572 17766677 17761835 11481614 17869086 12609069 15931870 12649538 18472094 18279442 12389079 16011737 12632514 18156304 17698563 17976157 17481882 18429990 15338365 12741479 15925388 18205269 17922224 18395095 14620537 17640975 17805973 15959796 17708605 12958196 18006644 12632512 14716496 15996030 18210741 18187930 14748882 15362042 18251166 15052691 17721639 18418968 14724832 10355542 17525996 16033810 15893842 17565644 18339082 12586293 20821823 17944888 15123356 15876570 18277467 18166357 18317297 18263696 15650968 18481824 12445421 16027843 16097048 17900296 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Cysteine |
18.41 | 15158331 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
18.41 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethyl Sulfoxide |
18.41 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
18.41 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
18.41 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
18.41 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Melatonin |
18.41 | 15925388 16703270 15298665 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
oltipraz |
18.41 | 16544323 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
18.41 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Plant Extracts |
18.41 | 15479170 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
18.41 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
18.41 | 12679928 18032466 11481614 16248980 15075984 15716488 12557150 16126171 18263696 17629604 15288473 18380797 10677585 17355460 15095483 18031379 17050028 18458672 12085344 15474484 12891558 18295389 16098781 17292413 12531686 15316131 16511523 11172339 15362042 15078482 18606216 11682029 14739098 15158331 17127702 16343077 15334695 15288472 18615449 16097051 18416461 16489207 15465738 18395095 12175628 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
18.41 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
26.77 | 12969438 16610002 19460945 12587719 19014921 11587558 19784758 16611625 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
26.77 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
26.77 | 16246199 15720792 16964402 17285989 15830285 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
26.77 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
26.77 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Fluconazole |
26.77 | 14966256 |
MESH:D008107 |
Liver Diseases |
|
Hemin |
26.77 | 17173083 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
26.77 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Plant Extracts |
26.77 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
propiconazole |
26.77 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
26.77 | 18374380 15158337 16337175 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
26.77 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Vinyl Chloride |
26.77 | 15211785 16270392 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
7.54 | 17207112 17347304 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
7.54 | 17207112 16737972 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
2.97 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.91 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.91 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
9.91 | 15313186 12479984 15633222 17276928 |
MESH:D008113 |
Liver Neoplasms |
|
1,3-butadiene |
58.40 | 2208121 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
58.40 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
58.40 | 14678523 18001218 10737359 10672840 11376686 16273603 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
58.40 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
58.40 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
58.40 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
58.40 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
58.40 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
ciprofibrate |
58.40 | 12771043 |
MESH:D008113 |
Liver Neoplasms |
|
dicyclanil |
58.40 | 20118626 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
58.40 | 20501860 21047994 20118626 19090486 18978307 19833225 12112319 21071580 18644402 15885732 19294768 19255062 19638242 20434301 19426721 9163691 18648771 19427195 18977376 2422723 18754104 19551842 19690152 19850985 19499222 21167192 20101389 20137499 21278145 19996281 20452335 19073162 19254457 16942905 15175105 20405173 19812893 20583210 2862719 20492335 12771043 19256749 19642983 10737359 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
58.40 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
oxfendazole |
58.40 | 18754104 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
58.40 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
58.40 | 15975961 19812893 8742319 21047994 19482888 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Piperonyl Butoxide |
58.40 | 18648771 15890375 20101389 19690152 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
58.40 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Plant Extracts |
58.40 | 19168119 |
MESH:D008113 |
Liver Neoplasms |
|
propiconazole |
58.40 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
58.40 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
58.40 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
Vinyl Chloride |
58.40 | 12211074 12762079 11024202 10629081 11679801 10964802 15999577 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
57.26 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
57.26 | 1399818 6150874 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
57.26 | 598648 6587162 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxins |
57.26 | 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
57.26 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
57.26 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
57.26 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
57.26 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
57.26 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
57.26 | 19004024 18775883 19519916 18079962 17942915 18544905 18308698 19009564 2563599 17174075 19126423 19539802 17854601 16267830 3124819 21159647 18093689 18253720 16842330 9362446 18164116 18282651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
57.26 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Hexachlorobenzene |
57.26 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
57.26 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
57.26 | 1399818 6150874 17172636 2563599 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
propiconazole |
57.26 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
styrene oxide |
57.26 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
57.26 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
57.26 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vinyl Chloride |
57.26 | 12562636 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
5.34 | 15213294 |
MESH:D008133 |
Long QT Syndrome |
|
Quinidine |
5.34 | 11989578 15350150 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
10.01 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
Fluconazole |
10.01 | 14966256 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
10.01 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
10.01 | 19066396 8266340 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
7.59 | 14698565 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
7.59 | 18516814 |
MESH:D055370 |
Lung Injury |
|
naphthalene |
5.73 | 6834280 |
MESH:D055370 |
Lung Injury |
|
Ozone |
5.73 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
1,3-butadiene |
50.31 | 2208121 16860786 17372256 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
50.31 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
9-deoxy-delta-9-prostaglandin D2 |
50.31 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
50.31 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
50.31 | 17976673 17306315 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
50.31 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
50.31 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos |
50.31 | 12111688 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
50.31 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
50.31 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
50.31 | 17053015 18569708 6695378 20464547 20064080 18816296 20135361 18520028 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
50.31 | 17225452 11798837 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
50.31 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
50.31 | 6695378 20970405 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
50.31 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
50.31 | 11497255 11053908 16537180 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
50.31 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
50.31 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Melatonin |
50.31 | 17195641 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
50.31 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
50.31 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Plant Extracts |
50.31 | 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Polycyclic Hydrocarbons, Aromatic |
50.31 | 10814675 |
MESH:D008175 |
Lung Neoplasms |
|
Styrene |
50.31 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
50.31 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vincristine |
50.31 | 19825857 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Vinyl Chloride |
50.31 | 12958735 12562636 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
4.26 | 16628512 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Melatonin |
4.26 | 16373423 |
MESH:D008223 |
Lymphoma |
|
1,3-butadiene |
16.76 | 17941976 9205081 18798262 8764131 9488045 11980663 2208121 |
MESH:D008223 |
Lymphoma |
|
Benzene |
16.76 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
Chlorambucil |
16.76 | 10745627 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
16.76 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
16.76 | 12854902 12556972 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
16.76 | 17352296 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
5.47 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
5.47 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
3.38 | 15621674 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.15 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
1,3-butadiene |
14.34 | 2208121 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
14.34 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Styrene |
14.34 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Vinyl Chloride |
14.34 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
1,3-butadiene |
9.37 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
9.37 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
9.37 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.37 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
methyleugenol |
9.37 | 11921183 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.12 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
8.75 | 12393984 16248763 18332650 17761969 12883367 18505091 18176117 15577323 11135225 12374674 16432458 17023156 16809738 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
8.75 | 17334785 12202904 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
8.75 | 16827129 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
8.75 | 17237267 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
8.75 | 12025231 16342250 12040289 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.75 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
8.75 | 19082730 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
8.08 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Vincristine |
8.08 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.38 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.04 | 18411066 15451040 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.23 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
4.52 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
4.52 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
4.42 | 9014606 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
4.42 | 9294310 |
MESH:D008654 |
Mesothelioma |
marker/mechanism |
|
| 17290392 |
MESH:D008654 |
Mesothelioma |
|
Asbestos |
6.33 | 18709470 16564556 18310086 16319530 16919927 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.33 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.33 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
3.36 | 19142101 |
MESH:D008679 |
Metaplasia |
|
Ozone |
3.87 | 10496685 |
MESH:D008708 |
Methemoglobinemia |
|
4-chloronitrobenzene |
4.92 | 3710033 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
2.74 | 11903285 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.37 | 15792986 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.08 | 9294310 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
5.28 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
5.28 | 12636206 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
8.49 | 17415656 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
8.49 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
9.39 | 15949261 11468182 14977855 19417148 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
9.39 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
9.39 | 15867202 16118317 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
9.39 | 14749477 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
4.43 | 17086897 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.32 | 16239165 |
MESH:D009181 |
Mycoses |
|
Iron |
4.23 | 16640825 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.44 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.33 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
7.33 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.33 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.49 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.49 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Vincristine |
5.49 | 17284715 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.35 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
9.35 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.35 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
5.24 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
5.24 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.26 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
8.76 | 20399394 |
MESH:D009224 |
Myotonia Congenita |
|
Quinine |
8.76 | 1896199 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
20.75 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
20.75 | 18551238 7678174 |
MESH:D009336 |
Necrosis |
|
2-nitropropane |
20.75 | 12195237 |
MESH:D009336 |
Necrosis |
|
Melatonin |
20.75 | 12195237 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
20.75 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
2.80 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
10.43 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
10.43 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
10.43 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
10.43 | 16537180 11239499 11053908 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
10.43 | 15867366 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
9.69 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
9.69 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
9.69 | 16773208 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
9.69 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
9.69 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Vinyl Chloride |
9.69 | 11911487 |
MESH:D009374 |
Neoplasms, Experimental |
|
1,3-butadiene |
8.94 | 9488045 9205081 8764131 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
8.94 | 10663608 15625704 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
8.94 | 1670384 |
MESH:D016609 |
Neoplasms, Second Primary |
marker/mechanism |
|
| 16703596 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
3.22 | 15738583 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.28 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
3.57 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
6.17 | 15640375 16889571 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
6.17 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
2.72 | 16893418 |
MESH:D009422 |
Nervous System Diseases |
|
Carbon Disulfide |
4.66 | 10669001 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
9.81 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.81 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.81 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
13.00 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
13.00 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
13.00 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
13.00 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
13.00 | 9142499 |
MESH:D019954 |
Neurobehavioral Manifestations |
|
Plant Extracts |
3.99 | 17168769 |
MESH:D009447 |
Neuroblastoma |
|
1,3-butadiene |
9.67 | 15814359 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
9.67 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
9.67 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
9.67 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
11.54 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
11.54 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
11.54 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
11.54 | 17296847 16604332 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
7.81 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Vincristine |
7.81 | 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
3.23 | 17056641 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
3.88 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Carbon Disulfide |
8.44 | 15315294 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
8.44 | 15081274 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Insecticides |
8.44 | 19861644 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
2.85 | 7688884 16761898 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
3.76 | 9802331 |
MESH:D009669 |
Nose Neoplasms |
|
Epichlorohydrin |
5.55 | 4038687 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
8.42 | 17217161 |
MESH:D009765 |
Obesity |
|
Clozapine |
8.42 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
8.42 | 21332399 18674790 17217161 20132043 16723640 19632207 18457598 11836018 20518802 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
8.42 | 20558911 |
MESH:D009765 |
Obesity |
|
Plant Extracts |
8.42 | 19056576 20132043 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
3.93 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
35.76 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
35.76 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
35.76 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diphenylmethane diisocyanate |
35.76 | 8156442 6091945 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
35.76 | 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
35.76 | 17119257 16737584 17178637 15935809 17479406 15727169 15576619 15913788 15612468 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
35.76 | 3040596 18394133 6091946 11077013 6091945 12585506 8156442 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
35.76 | 17852074 12819281 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Vinyl Chloride |
35.76 | 12061072 |
MESH:D014009 |
Onychomycosis |
|
Fluconazole |
5.12 | 14966256 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
3.78 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
5.03 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
5.03 | 16640825 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
3.77 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
8.07 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
8.07 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Iron |
3.00 | 16640825 16648989 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.07 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
1,3-butadiene |
13.47 | 2208121 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
13.47 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
13.47 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
13.47 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
13.47 | 19769630 6897625 15464296 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
13.47 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
13.47 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
10.43 | 16870215 |
MESH:D010146 |
Pain |
|
Benzoxazoles |
10.43 | 2357250 |
MESH:D010146 |
Pain |
|
Carbamazepine |
10.43 | 15215642 |
MESH:D010146 |
Pain |
|
Indomethacin |
10.43 | 17440234 13679232 17627676 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
10.43 | 16870215 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
3.46 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
14.67 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
14.67 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
14.67 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
14.67 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
14.67 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
14.67 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
14.67 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
8.19 | 15028970 17883296 |
MESH:D010195 |
Pancreatitis |
|
Insecticides |
8.19 | 3421227 16258382 |
MESH:D010195 |
Pancreatitis |
|
Methyldopa |
8.19 | 10484002 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.54 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
16.70 | 7296757 |
MESH:D010212 |
Papilloma |
|
cumene hydroperoxide |
16.70 | 12065085 17234724 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
16.70 | 12065085 |
MESH:D010212 |
Papilloma |
|
Iron |
16.70 | 12065085 |
MESH:D010212 |
Papilloma |
|
Plant Extracts |
16.70 | 15173996 16517061 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.01 | 19927285 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
4.48 | 16537180 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
4.50 | 16538176 |
MESH:D020447 |
Parasomnias |
|
Iron |
4.78 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Ditiocarb |
7.00 | 11445065 |
MESH:D010300 |
Parkinson Disease |
|
Eugenol |
7.00 | 17329831 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
7.00 | 16640825 16563566 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
7.00 | 16140633 12911755 15824117 15451049 11124998 11445065 11181820 16510128 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
3.24 | 16190885 |
MESH:D020734 |
Parkinsonian Disorders |
|
Carbon Disulfide |
9.36 | 15019297 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
9.36 | 12349958 |
MESH:D020734 |
Parkinsonian Disorders |
|
Melatonin |
9.36 | 15574749 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
4.70 | 17679678 17145499 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
4.48 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.01 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
3.93 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
3.68 | 17225004 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
6.21 | 16093927 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
6.21 | 15464296 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
3.77 | 16905509 6392382 15371236 |
MESH:D010538 |
Peritonitis |
|
Melatonin |
6.65 | 15707874 |
MESH:D010538 |
Peritonitis |
|
Ozone |
6.65 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
8.91 | 6228378 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
8.91 | 11550810 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
3.92 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
4.43 | 16604332 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
9.84 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
9.84 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
7.06 | 18929643 18007984 18381685 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
7.06 | 12504350 |
MESH:D011041 |
Poisoning |
|
Diazinon |
8.13 | 17603234 |
MESH:D011041 |
Poisoning |
|
Iron |
8.13 | 16604332 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
8.13 | 15727166 |
MESH:D017285 |
Polymyositis |
|
Vinyl Chloride |
5.62 | 11642524 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
4.76 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Hexachlorobenzene |
12.07 | 9918132 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
12.07 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
12.07 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
5.52 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
5.52 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
10.80 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Daunorubicin |
10.80 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
10.80 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Vincristine |
10.80 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
3.41 | 16640825 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
3.97 | 9014606 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
3.93 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
17.97 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
17.97 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
17.97 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Pesticides |
17.97 | 17938740 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.97 | 11399792 11222880 11896295 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 11275366 18304461 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.08 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.08 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.08 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.08 | 16868541 16729912 15749863 18437689 16888761 15897917 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estrogens, Catechol |
2.08 | 17261777 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
2.08 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.08 | 16356831 16729912 17136230 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Plant Extracts |
2.08 | 14666653 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
Prednisone |
2.08 | 16888761 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
12.84 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
12.84 | 11849393 |
MESH:D011507 |
Proteinuria |
|
Prednisone |
12.84 | 16636307 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
12.84 | 16636307 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
4.78 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
5.55 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
5.55 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
8.49 | 12752131 9591791 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
8.49 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
2.84 | 17410198 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
3.77 | 11575062 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
4.70 | 18769834 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
5.88 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
5.88 | 11575062 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.57 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
8.81 | 14606601 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
8.81 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.50 | 17266442 17720292 17894541 10334151 17620002 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
5.50 | 17997886 16324872 |
MESH:D011658 |
Pulmonary Fibrosis |
|
troglitazone |
5.50 | 18162602 |
MESH:D011928 |
Raynaud Disease |
marker/mechanism |
|
| 16977343 |
MESH:D011928 |
Raynaud Disease |
|
Vinyl Chloride |
4.93 | 16977343 |
MESH:D000608 |
Renal Aminoacidurias |
|
Mercuric Chloride |
4.87 | 2918855 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
10.44 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
10.44 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
10.44 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
4.41 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
Superoxides |
4.41 | 18460982 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
4,4'-diphenylmethane diisocyanate |
8.94 | 7973495 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
8.94 | 11700416 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
8.94 | 11700416 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
4,4'-diphenylmethane diisocyanate |
6.11 | 16940033 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
6.11 | 20219652 7692837 16940033 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
9.65 | 17119214 16611668 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
9.65 | 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Pesticides |
9.65 | 17119214 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
2.66 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
11.07 | 16611668 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Pesticides |
11.07 | 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
11.07 | 18447907 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
3.54 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
5.57 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
5.57 | 16458197 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
4.42 | 16849425 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Thioctic Acid |
4.42 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
2.95 | 16116481 16283617 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
3.52 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
4.05 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
4.28 | 19075512 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
6.38 | 16767912 15675481 15625365 18313854 17203757 17710206 |
MESH:D012509 |
Sarcoma |
|
Vinyl Chloride |
6.38 | 12828392 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
15.16 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
15.16 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
15.16 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
15.16 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
3.58 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.99 | 18806925 11763009 11151749 20521326 19369910 20107430 17123785 20580759 17667964 17726453 20168265 18855531 16141801 20452607 20521320 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
2.99 | 1830565 19369910 20107430 18513383 |
MESH:D012595 |
Scleroderma, Systemic |
|
Vinyl Chloride |
4.66 | 14979077 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
13.98 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
13.98 | 18551238 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
13.98 | 9844417 15946322 16876388 19414003 9046859 16938433 16180713 |
MESH:D012640 |
Seizures |
|
Ethanol |
13.98 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
13.98 | 3137016 16876388 11442880 4039156 |
MESH:D012640 |
Seizures |
|
Toluene |
13.98 | 6431079 9294310 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
13.98 | 18551238 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
3.60 | 6407741 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
4.85 | 6418539 |
MESH:D012871 |
Skin Diseases |
marker/mechanism |
|
| 16353154 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
6.90 | 15952646 19834688 17050553 17453740 16353154 17548696 17938729 16759981 16702368 6392382 18709164 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
6.90 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonic acid |
6.90 | 21378128 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
6.90 | 12880345 15451306 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
21.71 | 17050553 17976673 16251483 17029826 15504454 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
21.71 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
cumene hydroperoxide |
21.71 | 17234724 8532709 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
21.71 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
21.71 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
21.71 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Plant Extracts |
21.71 | 16517061 15173996 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
21.71 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
21.71 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
7.40 | 19414003 |
MESH:D012893 |
Sleep Disorders |
|
Melatonin |
7.40 | 18182647 16919138 16897403 |
MESH:D020178 |
Sleep Disorders, Circadian Rhythm |
|
Melatonin |
5.39 | 18078449 19452292 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Melatonin |
4.05 | 18078449 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.11 | 15464296 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
4.28 | 19075512 19050374 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.38 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
2.71 | 16709447 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
4.00 | 15817613 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
4.02 | 19694795 16415921 19915237 20485159 15057820 18855540 16538176 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
6.38 | 15472012 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
6.38 | 18545984 10486359 16184426 17207306 16113693 15472012 10192188 17160473 17638125 15038085 18209964 10215738 16280098 |
MESH:D013274 |
Stomach Neoplasms |
|
1,3-butadiene |
18.59 | 11397402 2208121 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
18.59 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
18.59 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
18.59 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Butylated Hydroxyanisole |
18.59 | 3581430 1399818 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
18.59 | 18396642 15958060 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
18.59 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
18.59 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
18.59 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
18.59 | 18506536 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
styrene oxide |
18.59 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
18.59 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
troglitazone |
18.59 | 15930296 |
MESH:D013274 |
Stomach Neoplasms |
|
Vinyl Chloride |
18.59 | 12562636 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
20.67 | 18726076 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
20.67 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
20.67 | 17189318 17918041 9562338 16755016 9211565 11906479 |
MESH:D013276 |
Stomach Ulcer |
|
Eugenol |
20.67 | 18543354 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
20.67 | 16934674 15104355 11595415 15138204 11729361 16150113 14567935 12077510 12498302 16397915 16169175 17918041 18237397 1323529 12500499 17135157 18726076 10750652 11523592 17895592 12787963 16755016 18087811 18543354 17657623 11906479 16252198 17627676 18181030 18431645 11145282 10423059 18193104 17977527 12467913 18209962 18299717 10878458 17654042 16631530 11595431 15255614 |
MESH:D013276 |
Stomach Ulcer |
|
Melatonin |
20.67 | 11523592 16150113 12500499 |
MESH:D013276 |
Stomach Ulcer |
|
pimagedine |
20.67 | 18209962 |
MESH:D013276 |
Stomach Ulcer |
|
Plant Extracts |
20.67 | 15255614 12787963 18237397 17135157 18193104 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
3.27 | 16403987 16517955 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.16 | 9754883 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
4.23 | 16640825 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Vincristine |
4.66 | 12837982 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
3.86 | 9562676 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
3.55 | 20210726 |
MESH:D024801 |
Tauopathies |
|
Daunorubicin |
7.91 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
7.91 | 16930453 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Plant Extracts |
4.24 | 17997062 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
10.63 | 15864552 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
10.63 | 6499806 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
10.63 | 10048760 10514026 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
3.48 | 15464296 17225452 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.47 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.09 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
3.74 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
2.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
22.19 | 1399818 6582329 7505956 6587162 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
22.19 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
22.19 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
22.19 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
22.19 | 11352223 14736730 18791128 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
22.19 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
22.19 | 16026305 17045167 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
22.19 | 17178689 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
2.69 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
2.76 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Iron |
5.16 | 16597321 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
5.16 | 16040207 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
3.68 | 17380554 10574470 |
MESH:D001749 |
Urinary Bladder Neoplasms |
marker/mechanism |
|
| 20972438 18505952 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
25.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
25.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
25.31 | 1399818 15289314 15867355 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
25.31 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
25.31 | 11144890 18640142 17976673 15987713 19322015 19429237 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
25.31 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
25.31 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Butylated Hydroxyanisole |
25.31 | 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
25.31 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
25.31 | 12973940 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
25.31 | 17653716 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.05 | 16487989 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
7.96 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
7.96 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
1.87 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
9.74 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
indole-3-carbinol |
9.74 | 16082211 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.74 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
5.73 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
5.73 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.37 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
3.59 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
3.42 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
3.52 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.35 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.42 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
6.58 | 17678736 16364871 17334414 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Plant Extracts |
6.58 | 18097624 |
MESH:D020257 |
Ventricular Remodeling |
|
Plant Extracts |
4.10 | 18097624 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
2.89 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
7.46 | 11897121 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
7.46 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.01 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
6.24 | 16402076 17502770 20564506 20107430 20521320 16141801 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
6.24 | 16723640 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
3.86 | 17933447 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
2.88 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Plant Extracts |
3.22 | 20213670 19894650 |